Cleared Traditional

K833617 - EXTRA PLUS TM

K833617 is an FDA 510(k) clearance for EXTRA PLUS TM, manufactured by American Surgical Co., Inc.. The device is a Class 2 Ophthalmic device with product code HQC cleared through the Traditional 510(k) pathway after a 75-day FDA review.

Download Printable Device Report (PDF)
Optimized for regulatory review, auditing and printing
Dec 1983
Decision
75d
Days
Class 2
Risk

K833617 is an FDA 510(k) clearance for the EXTRA PLUS TM. Classified as Unit, Phacofragmentation (product code HQC), Class II - Special Controls.

Submitted by American Surgical Co., Inc. (Walker, US). The FDA issued a Cleared decision on December 28, 1983 after a review of 75 days - a notably fast clearance cycle.

This device falls under the Ophthalmic FDA review panel, regulated under 21 CFR 886.4670 - the FDA ophthalmic device framework. The Traditional 510(k) pathway establishes clearance through substantial equivalence to a legally marketed predicate device, without requiring clinical trial data.

Device pattern: Fast-track predicate clearance. Standard predicate reliance. The short review cycle indicates strong predicate alignment - the FDA found sufficient equivalence without extended technical review.

FDA 510(k) Submission Details - K833617

510(k) Number K833617 FDA.gov
FDA Decision Cleared Substantially Equivalent - Traditional 510(k) (SESE)
Date Received October 14, 1983
Decision Date December 28, 1983
Days to Decision 75 days
Submission Type Traditional
Review Panel Ophthalmic (OP)
Summary -
Third-party Review No - reviewed directly by FDA
Combination Product No
PCCP Authorized No
Regulatory Context
Review time vs. panel average
35d faster than avg
Panel avg: 110d · This submission: 75d
Pathway characteristics
Predicate-based equivalence. No clinical trials required.

HQC Device Classification - Class 2, Special Controls

Product Code HQC Unit, Phacofragmentation
Device Class Class 2 - Special Controls
CFR Regulation 21 CFR 886.4670
What this classification means

Class II devices require demonstration of substantial equivalence to a legally marketed predicate device. This pathway does not require clinical trials - it relies on engineering equivalence and performance data. Most Ophthalmic devices follow this clearance model.

Regulatory Peers - HQC Unit, Phacofragmentation

All 316
Devices cleared under the same product code (HQC) and FDA review panel - the closest regulatory comparables to K833617.
M.S.D. ASPIRATOR
K832529 · Medical Surgical Designs · Jan 1984
STORZ EXTRA
K833064 · Storz Instrument Co. · Jan 1984
BEECHER 20 GA. PROBE
K833800 · Beecher Medical Diagnostic Instrumentation · Jan 1984
EXTRA SENSORY PAK-DISPOS. ACCESS
K833697 · American Surgical Co., Inc. · Dec 1983
EXTRA SENSORY PLUS
K834158 · American Surgical Co., Inc. · Dec 1983
PHACOTRON PLUS
K834159 · American Surgical Co., Inc. · Dec 1983